Clinical trial
Randomized, Double-blind, Single-center, Placebo-controlled Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds
NCT01434914 is registered in ClinicalTrials.gov with Schülke & Mayr GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-blind, Single-center, Placebo-controlled Study to Evaluate the Efficacy of Octenisept® in Patients With Chronic Wounds
- Lead sponsor
- Schülke & Mayr GmbH
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- October 31, 2011
- Completion date
- July 31, 2013
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ulcus cruris